nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR8—adipose tissue—polycystic ovary syndrome	0.0682	0.197	CbGeAlD
Imiquimod—TLR8—endocrine gland—polycystic ovary syndrome	0.0531	0.153	CbGeAlD
Imiquimod—TLR7—uterus—polycystic ovary syndrome	0.044	0.127	CbGeAlD
Imiquimod—TLR7—adrenal gland—polycystic ovary syndrome	0.0386	0.111	CbGeAlD
Imiquimod—CYP1A2—urine—polycystic ovary syndrome	0.0363	0.105	CbGeAlD
Imiquimod—TLR7—vagina—polycystic ovary syndrome	0.0358	0.103	CbGeAlD
Imiquimod—TLR7—endocrine gland—polycystic ovary syndrome	0.0335	0.0967	CbGeAlD
Imiquimod—CYP3A4—urine—polycystic ovary syndrome	0.0263	0.076	CbGeAlD
Imiquimod—Fungal infection—Metformin—polycystic ovary syndrome	0.0116	0.0469	CcSEcCtD
Imiquimod—Rigors—Metformin—polycystic ovary syndrome	0.011	0.0444	CcSEcCtD
Imiquimod—Nasal congestion—Metformin—polycystic ovary syndrome	0.00713	0.0289	CcSEcCtD
Imiquimod—Injury—Metformin—polycystic ovary syndrome	0.00706	0.0286	CcSEcCtD
Imiquimod—Lethargy—Metformin—polycystic ovary syndrome	0.00663	0.0268	CcSEcCtD
Imiquimod—Pain in extremity—Metformin—polycystic ovary syndrome	0.00649	0.0263	CcSEcCtD
Imiquimod—Migraine—Metformin—polycystic ovary syndrome	0.00639	0.0259	CcSEcCtD
Imiquimod—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00603	0.0174	CbGeAlD
Imiquimod—Breast disorder—Metformin—polycystic ovary syndrome	0.00587	0.0238	CcSEcCtD
Imiquimod—Influenza—Metformin—polycystic ovary syndrome	0.00561	0.0227	CcSEcCtD
Imiquimod—Sweating increased—Metformin—polycystic ovary syndrome	0.00547	0.0221	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00522	0.0211	CcSEcCtD
Imiquimod—Infestation NOS—Metformin—polycystic ovary syndrome	0.005	0.0203	CcSEcCtD
Imiquimod—Infestation—Metformin—polycystic ovary syndrome	0.005	0.0203	CcSEcCtD
Imiquimod—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.0049	0.0199	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—AKT2—polycystic ovary syndrome	0.00475	0.0117	CbGpPWpGaD
Imiquimod—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00473	0.0192	CcSEcCtD
Imiquimod—Rhinitis—Metformin—polycystic ovary syndrome	0.0045	0.0182	CcSEcCtD
Imiquimod—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00441	0.0179	CcSEcCtD
Imiquimod—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00436	0.0126	CbGeAlD
Imiquimod—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.00434	0.0107	CbGpPWpGaD
Imiquimod—Eye disorder—Metformin—polycystic ovary syndrome	0.0042	0.017	CcSEcCtD
Imiquimod—Flushing—Metformin—polycystic ovary syndrome	0.00417	0.0169	CcSEcCtD
Imiquimod—Angiopathy—Metformin—polycystic ovary syndrome	0.00408	0.0165	CcSEcCtD
Imiquimod—Immune system disorder—Metformin—polycystic ovary syndrome	0.00406	0.0164	CcSEcCtD
Imiquimod—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00405	0.0164	CcSEcCtD
Imiquimod—Chills—Metformin—polycystic ovary syndrome	0.00403	0.0163	CcSEcCtD
Imiquimod—Malnutrition—Metformin—polycystic ovary syndrome	0.00391	0.0158	CcSEcCtD
Imiquimod—Erythema—Metformin—polycystic ovary syndrome	0.00391	0.0158	CcSEcCtD
Imiquimod—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.00388	0.00953	CbGpPWpGaD
Imiquimod—TLR8—Immune System—UBE2H—polycystic ovary syndrome	0.00376	0.00924	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FBXO44—polycystic ovary syndrome	0.00376	0.00924	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—AKT2—polycystic ovary syndrome	0.00371	0.00911	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00363	0.0147	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—AKT2—polycystic ovary syndrome	0.0036	0.00884	CbGpPWpGaD
Imiquimod—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.00353	0.00867	CbGpPWpGaD
Imiquimod—Malaise—Metformin—polycystic ovary syndrome	0.00353	0.0143	CcSEcCtD
Imiquimod—Syncope—Metformin—polycystic ovary syndrome	0.00351	0.0142	CcSEcCtD
Imiquimod—Palpitations—Metformin—polycystic ovary syndrome	0.00346	0.014	CcSEcCtD
Imiquimod—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00344	0.0139	CcSEcCtD
Imiquimod—CYP1A2—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00341	0.00838	CbGpPWpGaD
Imiquimod—Hypertension—Metformin—polycystic ovary syndrome	0.00338	0.0137	CcSEcCtD
Imiquimod—Myalgia—Metformin—polycystic ovary syndrome	0.00333	0.0135	CcSEcCtD
Imiquimod—Chest pain—Metformin—polycystic ovary syndrome	0.00333	0.0135	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00331	0.0134	CcSEcCtD
Imiquimod—Discomfort—Metformin—polycystic ovary syndrome	0.00329	0.0133	CcSEcCtD
Imiquimod—Oedema—Metformin—polycystic ovary syndrome	0.00319	0.0129	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—FGF18—polycystic ovary syndrome	0.00318	0.00782	CbGpPWpGaD
Imiquimod—Infection—Metformin—polycystic ovary syndrome	0.00317	0.0128	CcSEcCtD
Imiquimod—Shock—Metformin—polycystic ovary syndrome	0.00314	0.0127	CcSEcCtD
Imiquimod—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00313	0.0127	CcSEcCtD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00312	0.00766	CbGpPWpGaD
Imiquimod—Skin disorder—Metformin—polycystic ovary syndrome	0.0031	0.0125	CcSEcCtD
Imiquimod—TLR8—Immune System—PTAFR—polycystic ovary syndrome	0.0031	0.00761	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00309	0.0125	CcSEcCtD
Imiquimod—Anorexia—Metformin—polycystic ovary syndrome	0.00304	0.0123	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00291	0.0118	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—GAB1—polycystic ovary syndrome	0.0029	0.00714	CbGpPWpGaD
Imiquimod—Paraesthesia—Metformin—polycystic ovary syndrome	0.00287	0.0116	CcSEcCtD
Imiquimod—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00285	0.00701	CbGpPWpGaD
Imiquimod—TLR7—Immune System—UBE2H—polycystic ovary syndrome	0.00285	0.00701	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FBXO44—polycystic ovary syndrome	0.00285	0.00701	CbGpPWpGaD
Imiquimod—Dyspnoea—Metformin—polycystic ovary syndrome	0.00285	0.0115	CcSEcCtD
Imiquimod—Somnolence—Metformin—polycystic ovary syndrome	0.00284	0.0115	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT2—polycystic ovary syndrome	0.00281	0.0069	CbGpPWpGaD
Imiquimod—Dyspepsia—Metformin—polycystic ovary syndrome	0.00281	0.0114	CcSEcCtD
Imiquimod—Decreased appetite—Metformin—polycystic ovary syndrome	0.00277	0.0112	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00276	0.0112	CcSEcCtD
Imiquimod—Fatigue—Metformin—polycystic ovary syndrome	0.00275	0.0111	CcSEcCtD
Imiquimod—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.00272	0.00669	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00263	0.00647	CbGpPWpGaD
Imiquimod—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00263	0.0106	CcSEcCtD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.00263	0.00646	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00261	0.0106	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—TNRC6B—polycystic ovary syndrome	0.0026	0.00638	CbGpPWpGaD
Imiquimod—Urticaria—Metformin—polycystic ovary syndrome	0.00254	0.0103	CcSEcCtD
Imiquimod—Abdominal pain—Metformin—polycystic ovary syndrome	0.00252	0.0102	CcSEcCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—polycystic ovary syndrome	0.00246	0.00605	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—polycystic ovary syndrome	0.00242	0.00594	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FGF18—polycystic ovary syndrome	0.00241	0.00592	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTAFR—polycystic ovary syndrome	0.00235	0.00577	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—polycystic ovary syndrome	0.00233	0.00573	CbGpPWpGaD
Imiquimod—Asthenia—Metformin—polycystic ovary syndrome	0.00229	0.00927	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—ATF1—polycystic ovary syndrome	0.00228	0.0056	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RACGAP1—polycystic ovary syndrome	0.00228	0.0056	CbGpPWpGaD
Imiquimod—Pruritus—Metformin—polycystic ovary syndrome	0.00226	0.00914	CcSEcCtD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00223	0.00547	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—GAB1—polycystic ovary syndrome	0.0022	0.00541	CbGpPWpGaD
Imiquimod—Diarrhoea—Metformin—polycystic ovary syndrome	0.00218	0.00884	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—polycystic ovary syndrome	0.00215	0.00528	CbGpPWpGaD
Imiquimod—Dizziness—Metformin—polycystic ovary syndrome	0.00211	0.00854	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—TAB1—polycystic ovary syndrome	0.0021	0.00517	CbGpPWpGaD
Imiquimod—Vomiting—Metformin—polycystic ovary syndrome	0.00203	0.00821	CcSEcCtD
Imiquimod—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00203	0.00498	CbGpPWpGaD
Imiquimod—Rash—Metformin—polycystic ovary syndrome	0.00201	0.00815	CcSEcCtD
Imiquimod—Dermatitis—Metformin—polycystic ovary syndrome	0.00201	0.00814	CcSEcCtD
Imiquimod—Headache—Metformin—polycystic ovary syndrome	0.002	0.00809	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TNRC6B—polycystic ovary syndrome	0.00197	0.00484	CbGpPWpGaD
Imiquimod—Nausea—Metformin—polycystic ovary syndrome	0.0019	0.00767	CcSEcCtD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00188	0.00462	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.00187	0.00459	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—polycystic ovary syndrome	0.00186	0.00458	CbGpPWpGaD
Imiquimod—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00186	0.00458	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FGF18—polycystic ovary syndrome	0.00185	0.00455	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—polycystic ovary syndrome	0.00183	0.0045	CbGpPWpGaD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00179	0.0044	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—polycystic ovary syndrome	0.00177	0.00434	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—ATF1—polycystic ovary syndrome	0.00173	0.00425	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RACGAP1—polycystic ovary syndrome	0.00173	0.00424	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00172	0.00422	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—NRG1—polycystic ovary syndrome	0.00172	0.00422	CbGpPWpGaD
Imiquimod—TLR8—Immune System—GAB1—polycystic ovary syndrome	0.00169	0.00416	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.00168	0.00412	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—polycystic ovary syndrome	0.00166	0.00407	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—polycystic ovary syndrome	0.00163	0.004	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TAB1—polycystic ovary syndrome	0.00159	0.00392	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00156	0.00384	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CAMK2D—polycystic ovary syndrome	0.00154	0.00378	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TNRC6B—polycystic ovary syndrome	0.00151	0.00372	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IRS2—polycystic ovary syndrome	0.00147	0.00361	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CRP—polycystic ovary syndrome	0.00147	0.00361	CbGpPWpGaD
Imiquimod—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00144	0.00353	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00142	0.0035	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FGF18—polycystic ovary syndrome	0.0014	0.00345	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00138	0.0034	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00138	0.0034	CbGpPWpGaD
Imiquimod—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00133	0.00326	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ATF1—polycystic ovary syndrome	0.00133	0.00326	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.0013	0.00321	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—NRG1—polycystic ovary syndrome	0.0013	0.00319	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00129	0.00316	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IRS1—polycystic ovary syndrome	0.00128	0.00315	CbGpPWpGaD
Imiquimod—TLR7—Immune System—GAB1—polycystic ovary syndrome	0.00128	0.00315	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.00127	0.00312	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—polycystic ovary syndrome	0.00126	0.00309	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TAB1—polycystic ovary syndrome	0.00123	0.00301	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00122	0.003	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PRL—polycystic ovary syndrome	0.00121	0.00298	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00121	0.00298	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.0012	0.00294	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—AKT2—polycystic ovary syndrome	0.00119	0.00292	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00119	0.00292	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CAMK2D—polycystic ovary syndrome	0.00116	0.00286	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TNRC6B—polycystic ovary syndrome	0.00115	0.00282	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CRP—polycystic ovary syndrome	0.00111	0.00274	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IRS2—polycystic ovary syndrome	0.00111	0.00274	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.00108	0.00266	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00106	0.0026	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—BCL2—polycystic ovary syndrome	0.00104	0.00255	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL18—polycystic ovary syndrome	0.00102	0.00251	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00101	0.00247	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ATF1—polycystic ovary syndrome	0.00101	0.00247	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NRG1—polycystic ovary syndrome	0.000999	0.00246	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000993	0.00244	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.000983	0.00242	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000983	0.00242	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IRS1—polycystic ovary syndrome	0.000972	0.00239	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000959	0.00236	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.000957	0.00235	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000957	0.00235	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000957	0.00235	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000947	0.00233	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000943	0.00232	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000936	0.0023	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TAB1—polycystic ovary syndrome	0.000929	0.00228	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000923	0.00227	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000921	0.00226	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PRL—polycystic ovary syndrome	0.00092	0.00226	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000916	0.00225	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT2—polycystic ovary syndrome	0.0009	0.00221	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000895	0.0022	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRS2—polycystic ovary syndrome	0.000856	0.0021	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CRP—polycystic ovary syndrome	0.000856	0.0021	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000816	0.00201	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—BCL2—polycystic ovary syndrome	0.000786	0.00193	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000778	0.00191	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL18—polycystic ovary syndrome	0.000774	0.0019	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000773	0.0019	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000763	0.00188	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000759	0.00186	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NRG1—polycystic ovary syndrome	0.000757	0.00186	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRS1—polycystic ovary syndrome	0.000747	0.00184	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00074	0.00182	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000738	0.00181	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000731	0.0018	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000711	0.00175	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT2—polycystic ovary syndrome	0.000691	0.0017	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000679	0.00167	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CRP—polycystic ovary syndrome	0.000648	0.00159	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRS2—polycystic ovary syndrome	0.000648	0.00159	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000634	0.00156	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000627	0.00154	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000625	0.00154	CbGpPWpGaD
Imiquimod—TLR8—Immune System—BCL2—polycystic ovary syndrome	0.000604	0.00148	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000602	0.00148	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.0006	0.00148	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000597	0.00147	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000589	0.00145	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000577	0.00142	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRS1—polycystic ovary syndrome	0.000566	0.00139	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000562	0.00138	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000554	0.00136	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6—polycystic ovary syndrome	0.000537	0.00132	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000524	0.00129	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT2—polycystic ovary syndrome	0.000524	0.00129	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000523	0.00129	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000522	0.00128	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000515	0.00127	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000489	0.0012	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000484	0.00119	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000483	0.00119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000476	0.00117	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000476	0.00117	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000467	0.00115	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BCL2—polycystic ovary syndrome	0.000458	0.00112	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000448	0.0011	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000445	0.00109	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000433	0.00107	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000427	0.00105	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000413	0.00102	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000407	0.001	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—polycystic ovary syndrome	0.000407	0.001	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000404	0.000992	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000403	0.00099	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000399	0.000979	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000397	0.000977	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000378	0.000928	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000361	0.000887	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00036	0.000886	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000333	0.000818	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000328	0.000807	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000319	0.000784	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000314	0.000773	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—polycystic ovary syndrome	0.000313	0.000768	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000306	0.000753	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000293	0.00072	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000279	0.000687	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000273	0.000671	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000268	0.000658	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000268	0.000658	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000265	0.00065	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000257	0.000632	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000253	0.000623	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000249	0.000612	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000248	0.00061	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000243	0.000598	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—polycystic ovary syndrome	0.000237	0.000582	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000227	0.000559	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000226	0.000556	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000216	0.00053	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000212	0.000521	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000212	0.000521	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000207	0.000508	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000207	0.000508	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000204	0.0005	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.0002	0.000493	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000192	0.000472	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000192	0.000471	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000177	0.000436	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000168	0.000414	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000163	0.000402	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000163	0.000402	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000161	0.000394	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000159	0.00039	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000143	0.000352	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000137	0.000337	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000136	0.000335	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000135	0.000332	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.00013	0.000319	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000128	0.000314	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000124	0.000306	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000124	0.000304	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000122	0.000299	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000118	0.00029	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.00011	0.000271	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000108	0.000266	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000105	0.000259	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000105	0.000258	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000101	0.000249	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	9.72e-05	0.000239	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.67e-05	0.000238	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.6e-05	0.000236	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	9.6e-05	0.000236	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.53e-05	0.000234	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.39e-05	0.000231	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	9.09e-05	0.000223	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	9.07e-05	0.000223	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	8.93e-05	0.000219	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.37e-05	0.000206	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.1e-05	0.000199	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.81e-05	0.000192	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TH—polycystic ovary syndrome	7.73e-05	0.00019	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	7.52e-05	0.000185	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.51e-05	0.000184	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.41e-05	0.000182	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	7.07e-05	0.000174	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7e-05	0.000172	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.89e-05	0.000169	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	6.31e-05	0.000155	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	6.01e-05	0.000148	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.96e-05	0.000147	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.8e-05	0.000143	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	5.7e-05	0.00014	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.45e-05	0.000134	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	5.31e-05	0.00013	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.87e-05	0.00012	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.64e-05	0.000114	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.4e-05	0.000108	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	4.31e-05	0.000106	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	4.25e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—INS—polycystic ovary syndrome	4.22e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.1e-05	0.000101	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.32e-05	8.17e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.28e-05	8.05e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.26e-05	8.01e-05	CbGpPWpGaD
